UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (199) 199
life sciences & biomedicine (198) 198
humans (188) 188
female (137) 137
male (137) 137
middle aged (133) 133
adult (113) 113
aged (113) 113
hematology (96) 96
oncology (88) 88
biological and medical sciences (74) 74
medical sciences (73) 73
life sciences (66) 66
lymphoma (59) 59
aged, 80 and over (56) 56
antineoplastic combined chemotherapy protocols - therapeutic use (54) 54
hematologic and hematopoietic diseases (54) 54
treatment outcome (54) 54
prognosis (52) 52
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (51) 51
abridged index medicus (48) 48
rituximab (46) 46
lymphomas (43) 43
cancer (40) 40
lymphoma, large b-cell, diffuse - drug therapy (36) 36
adolescent (33) 33
chemotherapy (33) 33
[sdv.can]life sciences [q-bio]/cancer (32) 32
disease-free survival (31) 31
young adult (29) 29
hemic and lymphatic diseases (27) 27
retrospective studies (27) 27
[sdv]life sciences [q-bio] (25) 25
cyclophosphamide - administration & dosage (25) 25
[ sdv.can ] life sciences [q-bio]/cancer (24) 24
doxorubicin - administration & dosage (23) 23
risk factors (23) 23
tumors (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
follow-up studies (22) 22
survival analysis (22) 22
prospective studies (21) 21
care and treatment (20) 20
lymphoma, large b-cell, diffuse - mortality (20) 20
vincristine - administration & dosage (20) 20
antineoplastic agents (19) 19
antineoplastic agents - therapeutic use (19) 19
kaplan-meier estimate (19) 19
lymphoma, large b-cell, diffuse - pathology (18) 18
neoplasm staging (18) 18
pharmacology. drug treatments (18) 18
prednisone - administration & dosage (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
cyclophosphamide - therapeutic use (17) 17
immune system diseases (17) 17
lymphoma, large b-cell, diffuse - genetics (17) 17
radiology, nuclear medicine & medical imaging (17) 17
fluorodeoxyglucose f18 (16) 16
pathology (16) 16
survival rate (16) 16
antibodies, monoclonal, murine-derived (15) 15
doxorubicin - therapeutic use (15) 15
lymphoma, follicular - drug therapy (15) 15
lymphoma, large b-cell, diffuse - diagnosis (15) 15
prednisone - therapeutic use (15) 15
antibodies, monoclonal, murine-derived - administration & dosage (14) 14
antibodies, monoclonal, murine-derived - therapeutic use (14) 14
clinical trials (14) 14
drug administration schedule (14) 14
positron-emission tomography - methods (14) 14
survival (14) 14
time factors (14) 14
human health and pathology (13) 13
medical research (13) 13
multivariate analysis (13) 13
mutation (13) 13
analysis (12) 12
combined modality therapy (12) 12
cyclophosphamide (12) 12
general & internal medicine (12) 12
medicine, general & internal (12) 12
pet (12) 12
predictive value of tests (12) 12
recurrence (12) 12
remission induction (12) 12
rituximab - administration & dosage (12) 12
antibodies, monoclonal - administration & dosage (11) 11
antineoplastic agents - administration & dosage (11) 11
b-cell lymphoma (11) 11
cyclophosphamide - adverse effects (11) 11
doxorubicin - adverse effects (11) 11
france (11) 11
lymphoma, follicular - pathology (11) 11
lymphoma, non-hodgkin - drug therapy (11) 11
patients (11) 11
tomography, x-ray computed (11) 11
toxicity (11) 11
transplantation, autologous (11) 11
vincristine - therapeutic use (11) 11
diagnosis, differential (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 460 - 468
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Journal Article
Journal Article
Journal Article